ALGS
Price
$10.25
Change
-$0.55 (-5.09%)
Updated
Sep 4, 10:56 AM (EDT)
Capitalization
75.07M
BEAM
Price
$18.19
Change
-$0.57 (-3.04%)
Updated
Sep 4, 02:46 PM (EDT)
Capitalization
1.9B
67 days until earnings call
Interact to see
Advertisement

ALGS vs BEAM

Header iconALGS vs BEAM Comparison
Open Charts ALGS vs BEAMBanner chart's image
Aligos Therapeutics
Price$10.25
Change-$0.55 (-5.09%)
Volume$645
Capitalization75.07M
Beam Therapeutics
Price$18.19
Change-$0.57 (-3.04%)
Volume$200
Capitalization1.9B
ALGS vs BEAM Comparison Chart in %
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. BEAM commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and BEAM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ALGS: $10.80 vs. BEAM: $18.76)
Brand notoriety: ALGS and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 30% vs. BEAM: 338%
Market capitalization -- ALGS: $75.07M vs. BEAM: $1.9B
ALGS [@Biotechnology] is valued at $75.07M. BEAM’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, ALGS is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 6 TA indicator(s) are bullish while BEAM’s TA Score has 6 bullish TA indicator(s).

  • ALGS’s TA Score: 6 bullish, 4 bearish.
  • BEAM’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ALGS and BEAM are a good buy in the short-term.

Price Growth

ALGS (@Biotechnology) experienced а -4.68% price change this week, while BEAM (@Biotechnology) price change was +11.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.02%. For the same industry, the average monthly price growth was +6.62%, and the average quarterly price growth was +28.65%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (-0.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.9B) has a higher market cap than ALGS($75.1M). BEAM YTD gains are higher at: -24.355 vs. ALGS (-72.892). ALGS has higher annual earnings (EBITDA): -75.81M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. ALGS (123M). ALGS has less debt than BEAM: ALGS (6.88M) vs BEAM (155M). BEAM has higher revenues than ALGS: BEAM (60.3M) vs ALGS (3.17M).
ALGSBEAMALGS / BEAM
Capitalization75.1M1.9B4%
EBITDA-75.81M-414.33M18%
Gain YTD-72.892-24.355299%
P/E RatioN/AN/A-
Revenue3.17M60.3M5%
Total Cash123M1.15B11%
Total Debt6.88M155M4%
TECHNICAL ANALYSIS
Technical Analysis
ALGSBEAM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBLGX64.35N/A
N/A
ClearBridge Large Cap Growth A
EATVX42.62N/A
N/A
Eaton Vance Tx-Mgd Value A
TWQCX16.05N/A
N/A
Transamerica Large Cap Value C
ANFVX15.73N/A
N/A
Virtus NFJ Small-Cap Value R6
VLPAX16.69N/A
N/A
Virtus Duff & Phelps Sel MLP & Engy A

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+1.69%
XNCR - ALGS
43%
Loosely correlated
-2.57%
RLAY - ALGS
40%
Loosely correlated
+12.02%
STRO - ALGS
39%
Loosely correlated
+3.93%
CRNX - ALGS
36%
Loosely correlated
+4.17%
RZLT - ALGS
34%
Loosely correlated
+0.98%
More